Current Liabilities: The sum of all liabilities classified as current for having maturities of less than one year.
4D Molecular Therapeutics, Inc. (FDMT) had Current Liabilities of $37.11M for the most recently reported fiscal quarter, ending 2025-09-30.
| Income Statement Financials | |
$0.09M |
|
$-56.88M |
|
-- |
|
$0.09M |
|
$61.27M |
|
$-61.19M |
|
$4.31M |
|
$-56.88M |
|
$-56.88M |
|
$-56.88M |
|
$-56.88M |
|
$-56.88M |
|
$-56.88M |
|
$-61.19M |
|
$-61.08M |
|
56.13M |
|
56.13M |
|
$-1.01 |
|
$-1.01 |
|
| Balance Sheet Financials | |
$312.38M |
|
$16.15M |
|
$111.61M |
|
$423.98M |
|
|
Current Liabilities |
$37.11M |
-- |
|
$17.89M |
|
$55.00M |
|
$368.98M |
|
$368.98M |
|
$368.98M |
|
46.77M |
|
| Cash Flow Statement Financials | |
$-137.63M |
|
$35.87M |
|
$0.98M |
|
$149.34M |
|
$48.55M |
|
$-100.78M |
|
$16.46M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
8.42 |
|
-- |
|
-- |
|
-- |
|
-- |
|
100.00% |
|
-67983.33% |
|
-67983.33% |
|
-- |
|
-63195.55% |
|
-63195.55% |
|
$-138.24M |
|
-- |
|
-- |
|
-- |
|
0.00 |
|
-- |
|
-- |
|
-- |
|
-15.41% |
|
-15.41% |
|
-13.41% |
|
-15.41% |
|
$7.89 |
|
$-2.46 |
|
$-2.45 |
|